Login to Your Account

Fanapt Comes (Almost) Full Circle

Vanda Inks $465M Novartis Deal, but Acquisition Not off the Table

By Trista Morrison

Wednesday, October 14, 2009
Five months after the surprise FDA approval of schizophrenia drug Fanapt (iloperidone), Vanda Pharmaceuticals Inc. nailed down a partner to launch the product. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription